Results of EXTRACT-PE Trial presented at Vascular InterVentional Advances (VIVA) Annual Meeting “The Indigo Aspiration System has demonstrated tremendous potential to address patients with clot in ...

Pulmonary embolism, or PE, is a deadly condition causing blood clots within a patient’s lungs that has grown in prevalence during the COVID-19 pandemic. The Indigo Aspiration System with Lightning 12 ...

The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), exenatide (Byetta, ...

New data from the Mayo Clinic provide added reassurance that the rate of pulmonary aspiration during upper gastrointestinal (GI) endoscopy is low in patients taking a glucagon-like peptide 1 (GLP-1) ...

(WXYZ) — The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy. A new warning highlights the risk of pulmonary ...

Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. There was also no significant difference in the odds of acute respiratory failure.

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — In the EXTRACT-PE trial, an aspiration mechanical thrombectomy device was safe and effective among ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for ...